Looks like 3M will sell their patch technology and manufacturing capability to anybody who has a drug that suits that type of delivery and puts up the dollars.
Should have no trouble working with GSK (through OBJ) or
any other future partners of OBJ (I reckon).
Looks like 3M will sell their patch technology and manufacturing...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable